PRESS RELEASE published on 05/03/2023 at 12:30, 1 year 6 months ago Empower Clinics Advances Research and Clinical Trials Division with The Signing of Another Experienced Principal Investigator
PRESS RELEASE published on 04/25/2023 at 12:30, 1 year 6 months ago Empower Clinics Accelerates Growth of Research and Clinical Trials Division with Signing of Two Additional Principal Investigators at First Site in Dallas, Texas
PRESS RELEASE published on 04/20/2023 at 12:30, 1 year 7 months ago Empower Clinics Announces Official Launch of Mobile Technology & Communications Platform, PulseIR Powered by Fobi
PRESS RELEASE published on 04/17/2023 at 12:30, 1 year 7 months ago Empower Clinics Signs Agreement To Conduct Research and Clinical Trials with Dallas, TX Based Medical Center - And Major Milestone With Signing Of Research Services Agreement With First Principal Investigator
PRESS RELEASE published on 03/21/2023 at 11:00, 1 year 8 months ago Empower Clinics Announces Exploration of Strategic Alternatives
PRESS RELEASE published on 03/20/2023 at 08:00, 1 year 8 months ago Empower Clinics Cancels Previously Announced Private Placement
PRESS RELEASE published on 03/07/2023 at 13:00, 1 year 8 months ago Empower Clinics Advances Partnership to Launch US Clinical Trial Management Services with Formation of Delaware Based Company and Identification of Principal Investigators
PRESS RELEASE published on 03/01/2023 at 01:20, 1 year 8 months ago CORRECTION: Empower Clinics Reports Q4 2022 Results
PRESS RELEASE published on 02/28/2023 at 23:00, 1 year 8 months ago Empower Clinics Reports Q4 2022 Results
PRESS RELEASE published on 02/27/2023 at 23:40, 1 year 8 months ago CORRECTION: Empower Clinics Announces FOBI Partnership To Elevate Investor Relations With Digital, Mobile and Personalized Engagement
Published on 11/21/2024 at 13:30, 36 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 36 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 31 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 51 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 8 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 46 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
